stella
beta
Pomalidomide, Rituximab and Orelabrutinib Combined With Polatuzumab Vedotin in the Treatment of Newly Diagnosed Elderly Patients With DLBCL — Stella
Home
/
Diffuse Large B-Cell Lymphoma
/
Pomalidomide, Rituximab and Orelabrutinib Combined With Polatuzumab Vedotin in the Treatment of Newly Diagnosed Elderly Patients With DLBCL
View on ClinicalTrials.gov
Recruiting
Back to Diffuse Large B-Cell Lymphoma trials
Pomalidomide, Rituximab and Orelabrutinib Combined With Polatuzumab Vedotin in the Treatment of Newly Diagnosed Elderly Patients With DLBCL
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(1 site)
China
The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu